Egetis Therapeutics AB (EGTX.ST) Q3 2024 Earnings

22AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.31
-0.28
-0.26
-0.23

Details

Expected EPS
-0.283644400328625
Actual EPS
-0.2388695718795
Surprise EPS
0.04
Surprise Percent
+15.79%

Description

Egetis Therapeutics AB (EGTX.ST) has reported earnings of -0.2388695718795 per share for Q3 2024.

0 Comments

Share your thoughts